Search - tctmd.com

Displaying 141 - 160 of 163

Sort: Relevancy | Date

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Daily News

Residual Syntax Score Predicts Outcome After Incomplete Revascularization

L.A. McKeown

April 10, 2012

News Daily News

La Puntuación Residual Syntax Predice los Resultados Tras una Revascularización Incompleta

L.A. McKeown

April 10, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

Presentation TCT 2012

Safety and Feasibility of Percutaneous Delivery of a Partial Left Ventricular Support Device (CircuLite® Synergy® Micro-Pump) in a Porcine Model

Presenter: Geng-Hua Yi, Yanping Cheng, Michael S. Aboodi, Armando Tellez, Gerard Conditt, Athanasios Peppas, Greg L. Kaluza, Rob Farnan, Arielle Drummond, Bryan Fritz, Gail Farnan, Daniel Burkhoff, Juan F. Granada

January 03, 2012

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Caitlin E. Cox

March 16, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

News Industry News

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

January 23, 2011

News

SYNTAX Published: CABG Remains Standard for Severe CAD

Caitlin E. Cox

February 18, 2009

Partner Content

SYNERGY-BP-DES-Optimizing Antiplatelet Therapy After PCI in Complex and High Bleeding Risk Patients - Boston Scientific

November 15, 2019

Video

» Topical Discussion

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

October 8, 2019

Partner Content

Complex PCI: Update on BP-DES, Focus on Clinical Trial Data with SYNERGY

June 25, 2018

Video

» Topical Discussion

The Synergy Stent: Clinical Evidence for Optimal Healing and Safety

May 11, 2018

Advertisement

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

Residual Syntax Score Predicts Outcome After Incomplete Revascularization

La Puntuación Residual Syntax Predice los Resultados Tras una Revascularización Incompleta

TCTMD’s Top 10 Most Popular News Stories From 2011

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Safety and Feasibility of Percutaneous Delivery of a Partial Left Ventricular Support Device (CircuLite® Synergy® Micro-Pump) in a Porcine Model

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

ESC Congress 2011: Drugs, Devices Work Together

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

SYNTAX Published: CABG Remains Standard for Severe CAD

SYNERGY-BP-DES-Optimizing Antiplatelet Therapy After PCI in Complex and High Bleeding Risk Patients - Boston Scientific

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

Complex PCI: Update on BP-DES, Focus on Clinical Trial Data with SYNERGY

The Synergy Stent: Clinical Evidence for Optimal Healing and Safety

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content